[ORGANIZATION]
Dr. Reddy’s Laboratories
Featured in 7 tracked stories · first seen
Situations
Lenacapavir HIV prevention rollout and generic approval
16 clusters · 142 sources · last updated
Latest: FDA approves generic lenacapavir for HIV prevention
Lenacapavir, a long-acting injectable medication for HIV pre-exposure prophylaxis (PrEP), has demonstrated high efficacy in clinical trials, reducing the risk of HIV transmission by 99.9%. The drug, which requires only t
Anvisa approval of GLP-1 medications in Brazil
2 clusters · 38 sources · last updated
Latest: Anvisa approves five new injectable pens for diabetes and obesity
Brazil’s National Health Surveillance Agency (Anvisa) has approved the registration of five new GLP-1 receptor agonist medication pens for treating diabetes and obesity. These new products include Aribet, Lyrza, and Wylo
Also covered in
-
Lenacapavir antiviral approved for HIV prevention in Mexico and US
[HEALTH] · 2 sources ·